RLMD logo

Relmada Therapeutics (RLMD) Short Term Debt

Annual Short Term Debt

N/A

31 December 2023

RLMD Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

N/A

30 September 2024

RLMD Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RLMD Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

RLMD Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time

Relmada Therapeutics Short Term Debt History

DateAnnualQuarterly
Sept 2020
-
$0.00(0.0%)
June 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(-100.0%)
Dec 2019
$110.20 K(-69.7%)
-
Sept 2019
-
$255.90 K(-29.7%)
June 2019
$364.20 K(+27.7%)
$364.20 K(+1164.6%)
Mar 2019
-
$28.80 K(-74.9%)
Dec 2018
-
$114.70 K(-42.7%)
Sept 2018
-
$200.20 K(-29.8%)
June 2018
$285.20 K(+3.1%)
$285.20 K(+922.2%)
Mar 2018
-
$27.90 K(-74.9%)
Dec 2017
-
$111.20 K(-42.7%)
Sept 2017
-
$194.20 K(-29.8%)
DateAnnualQuarterly
June 2017
$276.70 K(+1.1%)
$276.70 K(+902.5%)
Mar 2017
-
$27.60 K(-74.9%)
Dec 2016
-
$110.00 K(-33.1%)
Sept 2016
-
$164.40 K(-39.9%)
June 2016
$273.70 K(+3.8%)
$273.70 K(>+9900.0%)
Mar 2016
-
$0.00(-100.0%)
Dec 2015
-
$88.50 K(-49.8%)
Sept 2015
-
$176.40 K(-33.1%)
June 2015
$263.80 K(+351.7%)
$263.80 K(>+9900.0%)
Mar 2015
-
$0.00(-100.0%)
Dec 2014
-
$38.10 K(-74.3%)
Sept 2014
-
$148.30 K
June 2014
$58.40 K
-

FAQ

  • What is the all time high annual short term debt for Relmada Therapeutics?
  • What is the all time high quarterly short term debt for Relmada Therapeutics?

What is the all time high annual short term debt for Relmada Therapeutics?

Relmada Therapeutics all-time high annual short term debt is $364.20 K

What is the all time high quarterly short term debt for Relmada Therapeutics?

Relmada Therapeutics all-time high quarterly short term debt is $364.20 K